Selecting optimal first-line treatment for metastatic castration-resistant prostate cancer (CRPC)

Date 26 September 2014
Event ESMO 2014
Session Janssen: Navigating the evolving treatment landscape in mCRPC
Topics Anti-Cancer Agents & Biologic Therapy
Prostate Cancer
Presenter Cora Sternberg